The triple therapy inhaler delivers 3 active ingredients: beclomethasone dipropionate, an inhaled corticosteroid, formoterol fumarate, a long-acting beta-agonist, and glycopyrrolate, an ...

After 1 year of biologic therapy, admissions requiring noninvasive ventilation among patients with COPD and type 2 ...

For many years, treatment of asthma has focused on symptom management and control. As the understanding of disease processes has improved and treatments begin to target underlying mechanisms, there is ...

Due to chronic inflammation, those with COPD must learn to listen to what their bodies are telling them, writes columnist.

The Food and Drug Administration has granted Breakthrough Therapy designation to CD388 for seasonal influenza prevention.

Receiving dupilumab for 52 weeks lowered the risk for severe exacerbations vs. placebo in adults with COPD and type 2 ...

Combined treatments for both aspects of obstructive sleep apnea (OSA)—a compromised airway anatomy and unstable ...

Telemedicine significantly improved quality of life and inhaler technique in advanced COPD patients compared to traditional ...